Biofire FilmArray脑膜炎/脑炎检测 panel 对新型隐球菌/格特隐球菌检测的性能评估
该研究回顾性分析了1384例医生开具的脑膜炎/脑炎(ME)panel检测,比较其对隐球菌检测与脑脊液隐球菌抗原(CrAg)及培养的一致性。ME panel检测隐球菌的敏感性( vs 培养 96.4%, vs CrAg 83.8%)和特异性均高,但与CrAg一致性略低,且CrAg阳性而ME panel及培养阴性的标本均来自已治疗患者。
要点
- ME panel检测隐球菌与培养高度一致,敏感性96.4%,特异性99.6%。
- 与CSF CrAg相比敏感性83.8%,阴性结果需结合CrAg解读。
- 所有CrAg阳性而ME panel及培养阴性的标本均来自已治疗患者。
核心结论
- ME panel对隐球菌检测与CSF培养高度相关,与CSF CrAg相关性略低。
- 阴性ME panel结果预测培养无菌的潜在用途值得进一步研究。
研究设计与样本
- 回顾性分析2017年1月至2018年10月间医生开具的1384例ME panel检测。
- 将ME panel结果与脑脊液CrAg及培养比较,并确定隐球菌检测的临床意义。
主要发现
- 34例患者隐球菌检测阳性,占检测标本的2.7%(38/1384)。
- 34例阳性患者中85.3%(29/34)为HIV阳性。
- ME panel检出32/38(84.2%)阳性标本,培养检出28/38(73.7%),CSF CrAg阳性37/38(97.4%)。
- ME panel与培养相比敏感性96.4%(95% CI 81.7-99.9%),特异性99.6%(95% CI 99.2-99.9%)。
- ME panel与CSF CrAg相比敏感性83.8%(95% CI 68.0-93.8%),特异性99.9%(95% CI 99.6-100.0%)。
关键数值与推荐
- ME panel阴性且培养阴性的标本CrAg滴度低于ME panel阳性且培养阴性的标本(倒数中位终点滴度128±60 vs. 1920±1730,p=0.04)。
- 5例CrAg阳性而ME panel及培养阴性的标本均来自既往接受治疗的CM患者。
临床怎么用
- ME panel可作为隐球菌检测的快速方法,但阴性结果需结合CSF CrAg,尤其对已治疗患者。
- 阴性ME panel结果可能有助于预测培养无菌,但需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cryptococcal meningitis (CM) remains an important cause of morbidity and mortality among immunocompromised patients. Laboratory diagnostics for CM includes antigen detection, staining and culture. Data on the performance of the Biofire® FilmArray® meningitis/encephalitis (ME) panel for detecting Cryptococcus neoformans/gattii is limited, with several reports describing false negativity for this target. METHODS: A retrospective analysis of 1384 physician-ordered ME panel tests ordered between January 2017 to October 2018 was performed. ME panel results were compared to cerebrospinal fluid (CSF) cryptococcal antigen (CrAg) and CSF culture testing and clinical significance of cryptococcal detection was determined. RESULTS: There were 34 patients positive for cryptococcal detection by either ME panel, CSF CrAg or CSF culture in 2.7% of CSF specimens tested (38/1384). Of the 34 patients positive for cryptococcal detection, 85.3% were human immunodeficiency virus positive (29/34). The ME panel detected 32/38 (84.2%) cryptococcal-positive specimens, culture detected 28/38 (73.7%) and CSF CrAg was positive in 37/38 specimens (97.4%). The ME panel had a sensitivity and specificity of 96.4% (95% CI 81.7-99.9%) and 99.6% (95% CI 99.2-99.9%) compared with culture, and 83.8% (95% CI 68.0-93.8%) and 99.9% (95% CI 99.6-100.0%) compared to CSF CrAg testing, respectively. CrAg titres were lower among ME panel-negative, culture-negative specimens compared with ME panel-positive, culture-negative specimens (reciprocal median end-point titres of 128 ± 60 vs. 1920 ± 1730, p 0.04). All five CrAg-positive, ME panel- and culture-negative specimens were obtained from previously treated CM patients. DISCUSSION: The ME panel had high correlation with CSF culture and a somewhat lower correlation with CSF CrAg testing. The potential utility of using negative ME panel test results to predict culture sterility among patients undergoing treatment for CM warrants further study.
引用
- Van TT, Kim TH, Butler-Wu SM, et al. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii. Clin Microbiol Infect. 2020. PMID: 31972318. doi:10.1016/j.cmi.2020.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。